Home
BMRN
BMRN News

Latest BioMarin Pharmaceutical Inc. (BMRN) News on February 23, 2025

BioMarin price target raised to $80 from $78 at Scotiabank

TipRanks

2 days ago

BioMarin price target raised to $80 from $78 at Scotiabank

BioMarin Pharmaceutical Full Year 2024 Earnings: Beats Expectations

Simply Wall St.

2 days ago

BioMarin Pharmaceutical Full Year 2024 Earnings: Beats Expectations

Pfizer stops selling hemophilia gene therapy, citing weak demand

BioPharma Dive

2 days ago

Pfizer stops selling hemophilia gene therapy, citing weak demand

Why BioMarin Pharmaceutical Stock Zoomed Almost 5% Higher Today

Motley Fool

3 days ago

Why BioMarin Pharmaceutical Stock Zoomed Almost 5% Higher Today

Morningstar Research

3 days ago

Analyst Report: BioMarin Pharmaceutical Inc.

Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today

StockStory

3 days ago

Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today

MT Newswires

3 days ago

UBS Adjusts Price Target on BioMarin Pharmaceutical to $113 From $109, Maintains Buy Rating

Why Is BioMarin Stock Trading Higher On Thursday?

Benzinga

3 days ago

Why Is BioMarin Stock Trading Higher On Thursday?

BioMarin Q4 Earnings & Sales Top Estimates, Stock Up on Upbeat '25 View

Zacks

3 days ago

BioMarin Q4 Earnings & Sales Top Estimates, Stock Up on Upbeat '25 View

Thomson Reuters StreetEvents

3 days ago

Q4 2024 BioMarin Pharmaceutical Inc Earnings Call

Biomarin Pharmaceutical Inc (BMRN) Q4 2024 Earnings Call Highlights: Record Growth and ...

GuruFocus.com

3 days ago

Biomarin Pharmaceutical Inc (BMRN) Q4 2024 Earnings Call Highlights: Record Growth and ...

Compared to Estimates, BioMarin (BMRN) Q4 Earnings: A Look at Key Metrics

Zacks

4 days ago

Compared to Estimates, BioMarin (BMRN) Q4 Earnings: A Look at Key Metrics

BioMarin Pharmaceutical (BMRN) Surpasses Q4 Earnings and Revenue Estimates

Zacks

4 days ago

BioMarin Pharmaceutical (BMRN) Surpasses Q4 Earnings and Revenue Estimates

Associated Press Finance

4 days ago

BioMarin: Q4 Earnings Snapshot

BioMarin Pharmaceutical (NASDAQ:BMRN) Reports Bullish Q4, Stock Soars

StockStory

4 days ago

BioMarin Pharmaceutical (NASDAQ:BMRN) Reports Bullish Q4, Stock Soars

MT Newswires

4 days ago

BioMarin Pharmaceutical Q4 Non-GAAP Earnings, Revenue Rise; 2025 Outlook Set -- Shares Up After Hours

What To Expect From BioMarin Pharmaceutical’s (BMRN) Q4 Earnings

StockStory

5 days ago

What To Expect From BioMarin Pharmaceutical’s (BMRN) Q4 Earnings

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks

6 days ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?

Zacks

6 days ago

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?

BioMarin to Report Q4 Earnings: Here's What to Expect

Zacks

6 days ago

BioMarin to Report Q4 Earnings: Here's What to Expect

SpringWorks Therapeutics (SWTX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

10 days ago

SpringWorks Therapeutics (SWTX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Unveiling BioMarin (BMRN) Q4 Outlook: Wall Street Estimates for Key Metrics

Zacks

10 days ago

Unveiling BioMarin (BMRN) Q4 Outlook: Wall Street Estimates for Key Metrics

BMRN vs. CSLLY: Which Stock Is the Better Value Option?

Zacks

11 days ago

BMRN vs. CSLLY: Which Stock Is the Better Value Option?

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

11 days ago

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

11 days ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Why BioMarin Pharmaceutical Inc. (BMRN) Is Among the Best Healthcare Stocks To Buy According to Analysts

Insider Monkey

15 days ago

Why BioMarin Pharmaceutical Inc. (BMRN) Is Among the Best Healthcare Stocks To Buy According to Analysts

3 Reasons Growth Investors Will Love BioMarin (BMRN)

Zacks

18 days ago

3 Reasons Growth Investors Will Love BioMarin (BMRN)

BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET

PR Newswire

18 days ago

BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET

Zacks.com featured highlights BioMarin, Cheesecake Factory, Leidos and The Ensign

Zacks

18 days ago

Zacks.com featured highlights BioMarin, Cheesecake Factory, Leidos and The Ensign

Argus Research

19 days ago

BMRN: Rating increased to a HOLD

Tasso and Arup to develop blood testing services for clinical research

Medical Device Network

19 days ago

Tasso and Arup to develop blood testing services for clinical research

4 Stocks That Sport Impressive Interest Coverage Ratio

Zacks

19 days ago

4 Stocks That Sport Impressive Interest Coverage Ratio

Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings?

Zacks

20 days ago

Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings?

MT Newswires

20 days ago

BofA Adjusts Price Target on BioMarin Pharmaceutical to $99 From $100

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Zacks

24 days ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Argus Research

a month ago

BMRN: Raising target price to $51.00

FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication

Zacks

a month ago

FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication

Is BioMarin Pharmaceutical (BMRN) the Best Depressed Stock to Invest in Now?

Insider Monkey

a month ago

Is BioMarin Pharmaceutical (BMRN) the Best Depressed Stock to Invest in Now?

BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now?

Zacks

a month ago

BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now?

NVO Stock Rises as New Obesity Drug Shows Superior Weight Loss

Zacks

a month ago

NVO Stock Rises as New Obesity Drug Shows Superior Weight Loss

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Zacks

a month ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Why Is Andreas Halvorsen Bullish On BioMarin Pharmaceutical Inc. (BMRN) Now?

Insider Monkey

a month ago

Why Is Andreas Halvorsen Bullish On BioMarin Pharmaceutical Inc. (BMRN) Now?

Zacks.com featured highlights include BioMarin, Amazon.com, Leidos and The Ensign

Zacks

a month ago

Zacks.com featured highlights include BioMarin, Amazon.com, Leidos and The Ensign

These 4 Stocks Boast Impressive Interest Coverage Ratio

Zacks

a month ago

These 4 Stocks Boast Impressive Interest Coverage Ratio

Argus Research

a month ago

BMRN: Lowering target price to $50.00

Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study

Zacks

a month ago

Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study

Earnings are growing at BioMarin Pharmaceutical (NASDAQ:BMRN) but shareholders still don't like its prospects

Simply Wall St.

a month ago

Earnings are growing at BioMarin Pharmaceutical (NASDAQ:BMRN) but shareholders still don't like its prospects

BioMarin Pharmaceutical Inc. (BMRN) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025

Insider Monkey

a month ago

BioMarin Pharmaceutical Inc. (BMRN) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025

Here is Why Growth Investors Should Buy BioMarin (BMRN) Now

Zacks

a month ago

Here is Why Growth Investors Should Buy BioMarin (BMRN) Now

Zacks Industry Outlook Highlights Incyte, BioMarin, Exelixis, Halozyme and Blueprint Medicines

Zacks

a month ago

Zacks Industry Outlook Highlights Incyte, BioMarin, Exelixis, Halozyme and Blueprint Medicines

Argus Research

a month ago

BMRN: Lowering target price to $51.00

5 Biotech Stocks Worth Adding to Your Portfolio in 2025

Zacks

a month ago

5 Biotech Stocks Worth Adding to Your Portfolio in 2025

MT Newswires

a month ago

BioMarin Pharmaceutical Sues Ascendis Pharma for Alleged Patent Infringement in Germany

BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court

PR Newswire

a month ago

BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court

Wall Street Analysts Predict a 45.86% Upside in BioMarin (BMRN): Here's What You Should Know

Zacks

a month ago

Wall Street Analysts Predict a 45.86% Upside in BioMarin (BMRN): Here's What You Should Know

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock

Zacks

a month ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Zacks

a month ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Zacks

a month ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Zacks.com featured highlights include Leidos, Amazon.com, Halozyme Therapeutics and BioMarin Pharmaceutical

Zacks

2 months ago

Zacks.com featured highlights include Leidos, Amazon.com, Halozyme Therapeutics and BioMarin Pharmaceutical

These 4 Stocks Boast Impressive Interest Coverage Ratios

Zacks

2 months ago

These 4 Stocks Boast Impressive Interest Coverage Ratios

BioMarin to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 9:00 am PT / 12:00 pm ET, in San Francisco, CA

PR Newswire

2 months ago

BioMarin to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 9:00 am PT / 12:00 pm ET, in San Francisco, CA

10 Magnificent Stocks That Can Make You Richer in 2025

Motley Fool

2 months ago

10 Magnificent Stocks That Can Make You Richer in 2025

3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)

Zacks

2 months ago

3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)

BMRN or TECH: Which Is the Better Value Stock Right Now?

Zacks

2 months ago

BMRN or TECH: Which Is the Better Value Stock Right Now?

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term

Zacks

2 months ago

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

Zacks

2 months ago

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

Argus Research

2 months ago

BMRN: Lowering target price to $53.00

Is the Options Market Predicting a Spike in BioMarin Pharmaceutical (BMRN) Stock?

Zacks

2 months ago

Is the Options Market Predicting a Spike in BioMarin Pharmaceutical (BMRN) Stock?

Argus Research

2 months ago

BMRN: Rating decreased to a SELL

BioMarin Pharmaceutical (BMRN) is a Top-Ranked Momentum Stock: Should You Buy?

Zacks

2 months ago

BioMarin Pharmaceutical (BMRN) is a Top-Ranked Momentum Stock: Should You Buy?

Are BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

Simply Wall St.

2 months ago

Are BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

Argus Research

2 months ago

BMRN: Raising target price to $70.00

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks

2 months ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Morningstar Research

2 months ago

Analyst Report: BioMarin Pharmaceutical Inc.

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

3 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Why Is Beam Therapeutics (BEAM) Down 2.3% Since Last Earnings Report?

Zacks

3 months ago

Why Is Beam Therapeutics (BEAM) Down 2.3% Since Last Earnings Report?

Argus Research

3 months ago

BMRN: Lowering target price to $66.00

Why Is BioMarin (BMRN) Down 1.9% Since Last Earnings Report?

Zacks

3 months ago

Why Is BioMarin (BMRN) Down 1.9% Since Last Earnings Report?

Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Healthcare Stocks in 2024?

Insider Monkey

3 months ago

Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Healthcare Stocks in 2024?

Argus Research

3 months ago

BMRN: Raising target price to $68.00

MT Newswires

3 months ago

RBC Cuts Price Target on BioMarin Pharmaceutical to $70 From $80, Keeps Sector Perform Rating

Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?

Insider Monkey

3 months ago

Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock

Zacks

3 months ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Zacks

3 months ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

BioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right Now

Insider Monkey

3 months ago

BioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right Now

BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024

PR Newswire

3 months ago

BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024

MT Newswires

3 months ago

Wolfe Research Initiates BioMarin Pharmaceutical at Outperform With $95 Price Target

MT Newswires

3 months ago

Biomarin Pharmaceutical Insider Sold Shares Worth $350,324, According to a Recent SEC Filing

Argus Research

3 months ago

BMRN: What does Argus have to say about BMRN?

Implied Volatility Surging for BioMarin Pharmaceutical (BMRN) Stock Options

Zacks

3 months ago

Implied Volatility Surging for BioMarin Pharmaceutical (BMRN) Stock Options

Here’s Why BioMarin Aristotle Large Cap Growth Strategy Divested From Pharmaceutical (BMRN)

Insider Monkey

4 months ago

Here’s Why BioMarin Aristotle Large Cap Growth Strategy Divested From Pharmaceutical (BMRN)

BioMarin to Participate in Three Upcoming Investor Conferences

PR Newswire

4 months ago

BioMarin to Participate in Three Upcoming Investor Conferences

Argus Research

4 months ago

BMRN: Lowering target price to $69.00

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term

Zacks

4 months ago

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term

Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes"

Zacks

4 months ago

Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes"

BioMarin (BMRN) Upgraded to Buy: Here's Why

Zacks

4 months ago

BioMarin (BMRN) Upgraded to Buy: Here's Why

BMRN vs. INCY: Which Stock Is the Better Value Option?

Zacks

4 months ago

BMRN vs. INCY: Which Stock Is the Better Value Option?

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

Zacks

4 months ago

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)

GuruFocus.com

4 months ago

Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)

BioMarin price target raised to $106 from $104 at UBS

TipRanks

4 months ago

BioMarin price target raised to $106 from $104 at UBS

Share on Social Networks: